HRMY
USDHarmony Biosciences Holdings Inc. Common Stock
$30.720+1.470 (5.026%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$29.250
High
$30.890
Low
$27.660
Volume
1.44M
Company Fundamentals
Market Cap
1.8B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.82M
Exchange
NGM
Currency
USD
52-Week Range
Low $25.52Current $30.720High $40.93
Related News
BusinessWire
Harmony Biosciences Reports Strong Q3 2025 Financial Results; Recently Raised 2025 Revenue Guidance to $845-$865M
WAKIX® (pitolisant) Franchise Delivers Net Revenue of $239M in Q3 2025 (+29% YoY Growth) Record Increase in Average Number of Patients of Approximately 500 to Achieve 8,100 Average Patients in Q3 2025 Strong Cash
View more
BusinessWire
Harmony Biosciences Preannounces Strong Q3 2025 WAKIX Performance; Raises 2025 Revenue Guidance
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) today announced preliminary results for Q3 2025, highlighted by the following: WAKIX® (pitolisant) franchise delivered net revenue of approximately $239M in Q3
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.